Pulmonary-vein isolation with radiofrequency ablation as first-line therapy for atrial fibrillation
Rachael Williams
This article has no abstract so we have provided the first paragraph of the full text.
Treatment with antiarrhythmic drugs and anticoagulation is the current first-line therapy for patients with symptomatic atrial fibrillation (AF); however, this approach is often ineffective and is associated with serious clinical risk. Data from a small multicenter prospective randomized trial indicate that pulmonary-vein isolation (PVI) achieved by radiofrequency ablation might be a feasible alternative.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Mathematical physics Added dimensions to grain growthNature News and Views (26 Apr 2007)
